17-14206888-A-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000261643.8(COX10):c.1007A>T(p.Asp336Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D336G) has been classified as Pathogenic.
Frequency
Consequence
ENST00000261643.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX10 | NM_001303.4 | c.1007A>T | p.Asp336Val | missense_variant | 7/7 | ENST00000261643.8 | NP_001294.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COX10 | ENST00000261643.8 | c.1007A>T | p.Asp336Val | missense_variant | 7/7 | 1 | NM_001303.4 | ENSP00000261643 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152134Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000800 AC: 20AN: 250112Hom.: 0 AF XY: 0.0000739 AC XY: 10AN XY: 135282
GnomAD4 exome AF: 0.000134 AC: 196AN: 1461752Hom.: 0 Cov.: 32 AF XY: 0.000120 AC XY: 87AN XY: 727180
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74432
ClinVar
Submissions by phenotype
Mitochondrial complex 4 deficiency, nuclear type 3 Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 30, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 15, 2003 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 12, 2024 | Variant summary: COX10 c.1007A>T (p.Asp336Val) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-05 in 250112 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in COX10 causing Mitochondrial Complex 4 Deficiency, Nuclear Type 3, allowing no conclusion about variant significance. c.1007A>T has been reported in the literature in compound heterozygous individuals affected with Cytochrome c oxidase deficiency (Antonicka_2003, Riley_2020). These data indicate that the variant may be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function and this variant results in a catalytically inactive enzyme (Khalimonchuk_2012, Pitceathly_2013). The following publications have been ascertained in the context of this evaluation (PMID: 12928484, 22669974, 24100867, 32313153). ClinVar contains an entry for this variant (Variation ID: 7525). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 27, 2021 | - - |
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Aug 20, 2018 | - - |
Pathogenic, criteria provided, single submitter | research | Kids Research, The Children's Hospital at Westmead | - | - - |
not provided Pathogenic:1Other:1
not provided, no classification provided | in vitro | Johnston Lab, North Central College | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 22, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 336 of the COX10 protein (p.Asp336Val). This variant is present in population databases (rs104894557, gnomAD 0.02%). This missense change has been observed in individuals with clinical features consistent with mitochondrial complex IV deficiency (PMID: 12928484, 24100867, 32313153). ClinVar contains an entry for this variant (Variation ID: 7525). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COX10 protein function. Experimental studies have shown that this missense change affects COX10 function (PMID: 22669974, 24100867). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at